IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 33 filers reported holding IMPEL NEUROPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,836 | -66.1% | 25,200 | 0.0% | 0.00% | – |
| Q2 2023 | $32,004 | -9.3% | 25,200 | 0.0% | 0.00% | – |
| Q1 2023 | $35,280 | -87.5% | 25,200 | -66.4% | 0.00% | – |
| Q4 2022 | $281,250 | +38.5% | 75,000 | +79.9% | 0.00% | – |
| Q3 2022 | $203,000 | -47.8% | 41,700 | 0.0% | 0.00% | – |
| Q2 2022 | $389,000 | -66.1% | 41,700 | -76.8% | 0.00% | – |
| Q1 2022 | $1,147,000 | -21.3% | 180,045 | +6.6% | 0.00% | – |
| Q4 2021 | $1,458,000 | -7.2% | 168,938 | +31.0% | 0.00% | – |
| Q3 2021 | $1,571,000 | +283.2% | 128,974 | +178.6% | 0.00% | – |
| Q2 2021 | $410,000 | – | 46,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Norwest Venture Partners XIV, LP | 3,077,198 | $27,233,000 | 31.45% |
| 5AM Venture Management, LLC | 2,884,791 | $25,530,000 | 6.42% |
| venBio Partners LLC | 2,759,791 | $24,424,000 | 2.88% |
| LASRY MARC | 330,000 | $2,921,000 | 1.35% |
| Vivo Capital, LLC | 2,884,789 | $25,530,000 | 1.10% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,802,639 | $33,653,000 | 0.14% |
| Woodline Partners LP | 119,615 | $1,059,000 | 0.02% |
| Pinz Capital Management, LP | 6,188 | $55,000 | 0.02% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 230,238 | $2,019,000 | 0.02% |
| Zimmer Partners, LP | 25,000 | $221,000 | 0.00% |